Michael Laposata, MD, FCAP, comments on robots automating COVID antibody testing. “The ability to carry out more daily tests is the key to generating more data on individual immunity profiles that will help control the further spread of the virus,” states Dr. Laposata. “By transforming the rate at which testing can be carried out and eliminating the need for large numbers of laboratory staff being exposed to the potential risk of infection in manual testing, the automated system we’ve developed with ABB provides an accurate, fast, flexible and safe way of meeting our goals.”
For the full article click here: ABB uses robots to automate COVID antibody testing